256 related articles for article (PubMed ID: 16190504)
41. Bioenergetics in clinical medicine. VI. adjunctive treatment of periodontal disease with coenzyme Q10.
Wilkinson EG; Arnold RM; Folkers K
Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):715-9. PubMed ID: 785563
[TBL] [Abstract][Full Text] [Related]
42. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.
Rosenfeldt FL; Haas SJ; Krum H; Hadj A; Ng K; Leong JY; Watts GF
J Hum Hypertens; 2007 Apr; 21(4):297-306. PubMed ID: 17287847
[TBL] [Abstract][Full Text] [Related]
43. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection.
Russo R; Cavaliere F; Rombolà L; Gliozzi M; Cerulli A; Nucci C; Fazzi E; Bagetta G; Corasaniti MT; Morrone LA
Prog Brain Res; 2008; 173():575-82. PubMed ID: 18929135
[TBL] [Abstract][Full Text] [Related]
44. Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone).
Mortensen SA
Clin Investig; 1993; 71(8 Suppl):S116-23. PubMed ID: 8241694
[TBL] [Abstract][Full Text] [Related]
45. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.
NINDS NET-PD Investigators
Neurology; 2007 Jan; 68(1):20-8. PubMed ID: 17200487
[TBL] [Abstract][Full Text] [Related]
46. [Mitochondrial encephalopathy due to complex I deficiency. Brain tissue biopsy findings and clinical course following pharmacological].
Jiménez-Caballero PE; Mollejo-Villanueva M; Alvarez-Tejerina A
Rev Neurol; 2008 Jul 1-15; 47(1):27-30. PubMed ID: 18592477
[TBL] [Abstract][Full Text] [Related]
47. Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutation.
Remes AM; Liimatta EV; Winqvist S; Tolonen U; Ranua JA; Reinikainen K; Hassinen IE; Majamaa K
Neurology; 2002 Oct; 59(8):1275-7. PubMed ID: 12391367
[TBL] [Abstract][Full Text] [Related]
48. Cellular redox poise modulation; the role of coenzyme Q10, gene and metabolic regulation.
Linnane AW; Eastwood H
Mitochondrion; 2004 Sep; 4(5-6):779-89. PubMed ID: 16120432
[TBL] [Abstract][Full Text] [Related]
49. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study.
Chen RS; Huang CC; Chu NS
Eur Neurol; 1997; 37(4):212-8. PubMed ID: 9208260
[TBL] [Abstract][Full Text] [Related]
50. [Effects of coenzyme Q10 on ischemic myocardium during aortic cross-clamping for two hours--quantitative analysis of myocardial energy metabolism in LVH dogs (author's transl)].
Okamoto F; Abe T
Nihon Kyobu Geka Gakkai Zasshi; 1981 Jul; 29(7):1135-48. PubMed ID: 6457882
[No Abstract] [Full Text] [Related]
51. The beneficial effect of coenzyme Q10 and lipoic acid on obstructive bladder dysfunction in the rabbit.
Juan YS; Levin RM; Chuang SM; Hydery T; Li S; Kogan B; Schuler C; Huang CH; Mannikarottu A
J Urol; 2008 Nov; 180(5):2234-40. PubMed ID: 18804800
[TBL] [Abstract][Full Text] [Related]
52. Coenzyme Q10 and statins: biochemical and clinical implications.
Littarru GP; Langsjoen P
Mitochondrion; 2007 Jun; 7 Suppl():S168-74. PubMed ID: 17482884
[TBL] [Abstract][Full Text] [Related]
53. Coenzyme Q10 in cardiovascular disease.
Pepe S; Marasco SF; Haas SJ; Sheeran FL; Krum H; Rosenfeldt FL
Mitochondrion; 2007 Jun; 7 Suppl():S154-67. PubMed ID: 17485243
[TBL] [Abstract][Full Text] [Related]
54. Coenzyme q10: ubiquinone: a potent antioxidant and key energy facilitator for the heart.
Ross SM
Holist Nurs Pract; 2007; 21(4):213-4. PubMed ID: 17627201
[No Abstract] [Full Text] [Related]
55. Neuroprotection for Parkinson's disease.
LeWitt PA
J Neural Transm Suppl; 2006; (71):113-22. PubMed ID: 17447422
[TBL] [Abstract][Full Text] [Related]
56. [Biological properties of coenzyme Q10 and its effects on immunity].
Gazdík F; Piják MR; Borová A; Gazdíková K
Cas Lek Cesk; 2003; 142(7):390-3. PubMed ID: 14515440
[TBL] [Abstract][Full Text] [Related]
57. A clinical study of the effect of coenzyme Q on congestive heart failure.
Ishiyama T; Morita Y; Toyama S; Yamagami T; Tsukamoto N
Jpn Heart J; 1976 Jan; 17(1):32-42. PubMed ID: 778433
[TBL] [Abstract][Full Text] [Related]
58. Considerations for supplementing with coenzyme Q10 during statin therapy.
Levy HB; Kohlhaas HK
Ann Pharmacother; 2006 Feb; 40(2):290-4. PubMed ID: 16449543
[TBL] [Abstract][Full Text] [Related]
59. Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation.
Artuch R; Brea-Calvo G; Briones P; Aracil A; Galván M; Espinós C; Corral J; Volpini V; Ribes A; Andreu AL; Palau F; Sánchez-Alcázar JA; Navas P; Pineda M
J Neurol Sci; 2006 Jul; 246(1-2):153-8. PubMed ID: 16677673
[TBL] [Abstract][Full Text] [Related]
60. [The influence of Q10 coenzyme on structural and functional parameters of red blood cells in elderly people].
Kedziora-Kornatowska K; Kujawski K; Błaszczak R; Rysz J; Markuszewsk L; Koter M; Duchnowicz P; Kornatowski T; Olszewski R; Kedziora J
Pol Merkur Lekarski; 2006 Jan; 20(115):57-61. PubMed ID: 16617737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
